Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy.

about

Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy.

Item

http://www.wikidata.org/entity/Q53109578

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy.

@en

Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy.

@nl

type

Item

label

Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy.

@en

Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy.

@nl

prefLabel

Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy.

@en

Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy.

@nl

P1476

Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy

@en

P2093

Ji Won Kim

http://www.w3.org/2001/XMLSchema#string

Jin Joo Kim

http://www.w3.org/2001/XMLSchema#string

Yil Park

http://www.w3.org/2001/XMLSchema#string

Young Jun Woo

http://www.w3.org/2001/XMLSchema#string

Yuri Seo

http://www.w3.org/2001/XMLSchema#string

P2860

Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis

Graves' ophthalmopathy

A novel mechanism of plasmin-induced mitogenesis in fibroblasts.

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

CCN1/CYR61: the very model of a modern matricellular protein.

Rundle and his curve.

Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina.

Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.

Glucocorticoid-attenuated response genes encode intercellular mediators, including a new C-X-C chemokine.

Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding

P304

1094-1100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09273948.2017.1319960

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jin Sook Yoon

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28548552

http://www.w3.org/2001/XMLSchema#string